Diamond Biofund
Venture capitalTaipei · Seed–Series B · 6 people tracked
Find your way into Diamond Biofund
308 people in our graph share verified history with the Diamond Biofund team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Diamond Biofund positions itself as a sustainability-focused biotech venture capital firm aiming to identify top investment targets and maximize returns. It seeks out leading scientists in the life sciences and provides comprehensive professional resources, leveraging more than 25 years of new-drug R&D experience to help technologies succeed commercially and move from laboratory to market. The firm co-invests with large financial holding groups in a sustainable biotech fund to build flagship biotech enterprises, emphasizing precise investment and efficient support to grow portfolio companies' market value and deliver maximized returns for shareholders.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from the firm's website & public directoriesFrequently asked questions
- What stage does Diamond Biofund invest at?
- Diamond Biofund invests at the Seed, Series A, Series B stages.
- What sectors does Diamond Biofund focus on?
- Diamond Biofund focuses on Biotech, Medical Devices.
- Where is Diamond Biofund located?
- Diamond Biofund is headquartered in Taipei, TW.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Fluke Venture Partners is a Pacific Northwest venture firm that has funded technology, healthcare, and consumer companies for over three decades, working with management teams as long-term partners from early stages onward.
Roadmap Capital Inc. is an investment platform providing co-investment access to private companies in technology and healthcare/medtech sectors.
Jumpstart Ventures' Focus Fund invests in pre-seed and seed-stage companies that show early signs of product-market fit, typically those raising $500K-$2M rounds.





